These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8737523)

  • 1. [Overexpression of p53 as prognosis factor in vulvar carcinoma].
    Kohlberger P; Breitenecker G; Gitsch G; Sliutz G; Kölbl H; Tschachler E; Reinthaller A; Kainz C
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):40-1. PubMed ID: 8737523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter.
    Kagie MJ; Kenter GG; Tollenaar RA; Hermans J; Trimbos JP; Fleuren GJ
    Int J Gynecol Pathol; 1997 Apr; 16(2):124-30. PubMed ID: 9100065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb.
    Lerma E; Matias-Guiu X; Lee SJ; Prat J
    Int J Gynecol Pathol; 1999 Jul; 18(3):191-7. PubMed ID: 12090585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma.
    Kohlberger P; Kainz C; Breitenecker G; Gitsch G; Sliutz G; Kölbl H; Tschachler E; Reinthaller A
    Cancer; 1995 Nov; 76(10):1786-9. PubMed ID: 8625048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
    Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
    Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
    Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent prognostic factors in vulvar carcinoma: histological, immunohistochemical and flow cytometry studies].
    Weikel W; Beck T; Moll R; Brumm C; Knapstein PG
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():11-4. PubMed ID: 8672907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein expression in squamous cell carcinoma of the vulva.
    Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
    Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
    van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
    Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequent point mutations in the p53 tumor suppressor gene in human vulvar cancer].
    Speiser P; Schmid W; Czervenka K; Peschke M; Zeillinger R; Kubista E
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():31-2. PubMed ID: 1337493
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
    Bosch FX; Homann N; Conradt C; Dietz A; Erber R
    HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of apoptosis in squamous cell carcinoma of the vulva.
    Hantschmann P; Kürzl R
    J Reprod Med; 2000 Aug; 45(8):633-42. PubMed ID: 10986681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2 Gene Amplification and Overexpression is Linked to HPV-positive Vulvar Carcinomas.
    Gut A; Moch H; Choschzick M
    Int J Gynecol Pathol; 2018 Jan; 37(1):68-73. PubMed ID: 28700423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of p53, urokinase plasminogen activator, PAI-1 and Ki-67 in vulvar carcinoma].
    Hoffmann G; Casper F; Weikel W; Kümmerle T; Pollow B; Schaffrath M; Hofmann M; Pollow K
    Zentralbl Gynakol; 1999; 121(10):473-8. PubMed ID: 10573820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in epidermoid carcinoma of the vulva.
    Franklin EW; Rutledge FD
    Obstet Gynecol; 1971 Jun; 37(6):892-901. PubMed ID: 4378214
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of biomolecular and clinical prognostic factors in patients with cancer of the vulva undergoing surgical treatment.
    Zanvettor PH; Filho DF; Soares FA; Neves AR; Palmeira LO
    Int J Gynecol Cancer; 2014 May; 24(4):766-72. PubMed ID: 24552893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva.
    Gadducci A; Tana R; Barsotti C; Guerrieri ME; Genazzani AR
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):71-83. PubMed ID: 22015047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of p53 gene protein in squamous cell carcinoma and precancerous lesion of vulva].
    Su B; Wang K; Liu E
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):651-3. PubMed ID: 8745487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the Vulva.
    Pors J; Tessier-Cloutier B; Thompson E; Almadani N; Ho J; Gilks B; Huntsman D; Hoang L
    Int J Gynecol Pathol; 2021 Jul; 40(4):391-399. PubMed ID: 33323855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.